Skip to main content

Advertisement

Contact Odd Erik Johansen

From: Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

Contact corresponding author